IDXX
NASDAQ
US
IDEXX Laboratories, Inc. - Common Stock
$569,55
▲ +$4,89
(+0,87%)
Vol. 734K
11
Punteggio di Qualità
ok
Analisi approfondita
2/5
ok
Ricavi ✓
Utile netto ✓
>IPO ✗
Cap. mercato
$54.0B
P/E
52,6
ROE
67,8%
Margine
24,7%
D/E
62,76
Beta
1,67
52W
$356–$770
Consenso Wall Street
22 analisti · Apr 20267
Acquisto forte
9
Compra
6
Mantieni
0
Vendi
0
Vendita forte
72,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
Utili
Tasso di battuta: 100,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $2,99 | $3,08 | +$0,09 |
| Set 2025 | $3,19 | $3,40 | +$0,21 |
| Giu 2025 | $3,37 | $3,63 | +$0,26 |
| Mar 2025 | $2,91 | $2,96 | +$0,05 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $954.3M | $998.4M | $1.1B | $1.1B | $1.1B |
| Utile netto | $216.1M | $242.7M | $294.0M | $274.6M | $248.2M |
Trend fondamentali
| Metrica | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 64.4% | 64.4% | 64.4% | 64.4% | 67.8% | 67.8% |
| P/E (TTM) | 43.76 | 51.66 | 48.97 | 51.10 | 57.24 | 52.58 |
| Net Margin | 26.5% | 24.4% | 24.4% | 24.4% | 24.6% | 24.6% |
| Gross Margin | 62.6% | 61.5% | 61.5% | 61.5% | 61.7% | 61.7% |
| D/E Ratio | 75.66 | 75.66 | 75.66 | 75.66 | 62.76 | 62.76 |
| Current Ratio | 1.11 | 1.11 | 1.11 | 1.11 | 1.18 | 1.18 |
Rapporti chiave
ROA (TTM)
31,1%
P/S (TTM)
12,96
P/B
21,2
EPS (TTM)
$12,61
CF/Share
$11,16
Crescita ricavi 3A
+6,6%
52W High
$769,98
52W Low
$356,14
$356,14
Intervallo 52 settimane
$769,98
Salute finanziaria
Flusso di cassa libero
$326.1M
Debito netto
$796.0M
Liquidità
$180.1M
Debito totale
$976.1M
Aggiornato al Dic 31, 2025
Як IDXX виглядає на тлі конкурентів у Health Care?
Група порівняння: Micro-cap Health Care (All) · 241 компаній
Оцінка IDXX vs аналоги Health Care
P/E
52,6
▲
71%
sopra
peer
(30,7)
vs Peer
vs Settore
Sottovalutato
P/S
13,0
▲
402%
sopra
peer
(2,6)
vs Peer
vs Settore
Sopravvalutato
P/B
21,2
▲
663%
sopra
peer
(2,8)
vs Peer
vs Settore
Sopravvalutato
Дивідендна дохідність
—
▼
0%
sotto
peer
(0,7%)
vs Peer
vs Settore
Rendimento basso
Прибутковість IDXX vs аналоги Health Care
ROE
67,8%
▲
276%
sopra
peer
(-38,5%)
vs Peer
vs Settore
Top livello
Net margin
24,7%
▲
200%
sopra
peer
(-24,7%)
vs Peer
vs Settore
Top livello
Валова маржа
61,7%
▲
17%
sopra
peer
(52,9%)
vs Peer
vs Settore
Sotto media
ROA
31,1%
▲
246%
sopra
peer
(-21,2%)
vs Peer
vs Settore
Top livello
Фінансове здоровʼя IDXX vs аналоги Health Care
D/E ratio
62,8
▲
226%
sopra
peer
(19,3)
vs Peer
vs Settore
Debito alto
Поточна ліквідність
1,2
▼
45%
sotto
peer
(2,2)
vs Peer
vs Settore
Liquidità bassa
Beta
1,7
▲
59%
sopra
peer
(1,1)
vs Peer
vs Settore
Più volatile
Радар фундаменталів IDXX
IDXX
Mediana peer
Industria
IDXX прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
IDXX vs аналоги: ключові метрики
Segnali Correlati
Ultima opinione AI
Grok
SKIP
Price action shows a prolonged downtrend from peaks above $750 in late 2025 to current levels around $558, with recent weekly closes declining from $636 (Mar 2) to $557 (Mar 30), indicating no clear reversal or upward momentum yet, making …
Apr 01, 2026